Health
Antibody Cocktail Seems to Prevent COVID-19 Spread – Medscape
The antibody cocktail casirivimab and imdevimab may be an option to ward off infection, but the study didn’t quite reach statistical significance.
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
A one-time injection of the monoclonal antibody cocktail casirivimab with imdevimab (REGEN-COV), taken within 72 hours of a household member’s diagnosis with SARS-CoV-2, prevented 100% of COVID-19 illness, 100% of high SARS-CoV-2 viral loads, and cut length of asymptomatic infection to 1 week.
“It’s fantastic news,” said Rajesh Gandhi, MD, an infectious disease physician at Massachusetts General…
-
Noosa News21 hours agoTrucking company penalised for refusing to pay unfairly sacked worker
-
Noosa News16 hours agoTallest tower outside CBD approved for construction at 205 metres
-
Noosa News17 hours agoFarmgate Backpackers leads with integrity amid industry challenges
-
General23 hours agoVacherot becomes lowest-ranked ATP Masters winner after defeating his cousin Rinderknech in Shanghai